Skip to main content
. 2023 Oct 1;23(5):914–919. doi: 10.17305/bb.2022.8807

Table 1.

Baseline characteristics of study participants

Factor Level/units Visit 1 Visit 2 Visit 3
N ═ 27 N ═ 22 N ═ 19
Sex Male 6 (22.22%) 6 (27.27%) 3 (15.79%)
Female 21 (77.78%) 16 (72.73%) 16 (84.21%)
BMI category Normal 4 (14.81%) 3 (13.64%) 2 (10.53%)
Overweight 7 (25.93%) 6 (27.27%) 5 (26.32%)
Obese 16 (59.26%) 13 (59.09%) 12 (63.16%)
Bariatric surgery status No prior history 17 (62.96%) 13 (59.09%) 13 (68.42%)
Had a prior history 10 (37.04%) 9 (40.91%) 6 (31.58%)
Fat percent, median (IQR) % 37.00 (32.90, 42.20) 37.00 (32.90, 42.90) 39.60 (33.60, 44.00)
Biphasic shape of GTT No 23 (85.19%) 19 (86.36%) 15 (88.24%)
Yes 4 (14.81%) 3 (13.64%) 2 (11.76%)
Peak glucose after 30 min on the GTT No 7 (25.93%) 5 (22.73%) 4 (23.53%)
Yes 20 (74.07%) 17 (77.27%) 13 (76.475)
GTT0, median (IQR) mmol/L 5.30 (4.90, 5.80) 5.45 (5.00, 5.70) 5.20 (4.90, 9.00)
GTT15, median (IQR) mmol/L 7.90 (6.80, 9.70) 7.45 (7.00, 8.30) 8.00 (6.20, 9.00)
GTT30, median (IQR) mmol/L 8.60 (7.10, 11.20) 8.40 (7.70, 10.30) 8.95 (6.80, 10.70)
GTT45, median (IQR) mmol/L 10.40 (7.50, 12.00) 9.55 (8.40, 10.10) 8.10 (6.40, 10.70)
GTT60, median (IQR) mmol/L 8.90 (7.20, 12.60) 8.75 (7.60, 11.10) 8.35 (7.10, 11.50)
GTT120, median (IQR) mmol/L 6.70 (4.20, 8.80) 6.40 (5.30, 8.60) 5.75 (4.70, 8.20)

GTT: Glucose tolerance test; IQR: Interquartile range; BMI: Body mass index.